Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors

被引：0
|
作者：
Zi-yi Liu
Xue-feng Kan
Li-jie Zhang
Joyman Makamure
Qing Li
Dan Zhao
Guo-feng Zhou
Gan-sheng Feng
Chuan-sheng Zheng
Bin Liang
机构：
[1] Huazhong University of Science and Technology,Department of Radiology, Union Hospital, Tongji Medical College
[2] Hubei Province Key Laboratory of Molecular Imaging,undefined
来源：
Current Medical Science | 2022年 / 42卷
关键词：
chemoembolization; therapeutic; apatinib; molecular targeted therapy; survival; factor analysis; statistical;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1021
页数：6
相关论文
共 50 条
  • [41] Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes
    Kim, Ji Hoon
    Kim, Jin Hyoung
    Yoon, Hyun-Ki
    Ko, Gi-Young
    Shin, Ji Hoon
    Gwon, Dong Il
    Ko, Heung-Kyu
    Chu, Hee Ho
    Kim, Seong Ho
    Kim, Gun Ha
    Kim, Yonghun
    Aljerdah, Shakir
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma
    Le, Yong
    Shen, Jing-Xian
    Zhang, Yong-Fa
    He, Min-Ke
    Kan, Anna
    Chen, Hai-Long
    Yu, Zi-Shan
    Li, Qi-Jiong
    Shi, Ming
    JOURNAL OF CANCER, 2019, 10 (03): : 665 - 671
  • [43] SIB-IMRT combined with apatinib for unresectable hepatocellular carcinoma in patients with poor response to transarterial chemoembolization
    Liu, Xuefen
    Luo, Jiangping
    Zhang, Longbin
    Yang, Fan
    Peng, Dong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (06)
  • [44] Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
    Sangheun Lee
    Jung Hyun Kang
    Do Young Kim
    Sang Hoon Ahn
    Jun Yong Park
    Beom Kyung Kim
    Seung Up Kim
    Kwang-Hyub Han
    Hepatology International, 2017, 11 : 292 - 299
  • [45] Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma
    He, Ying
    Lin, Wangchun
    Cai, Zhongjie
    Huang, Yufan
    You, Maojin
    Lei, Meisheng
    Chen, Ruijia
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [46] Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
    Lee, Sangheun
    Kang, Jung Hyun
    Kim, Do Young
    Ahn, Sang Hoon
    Park, Jun Yong
    Kim, Beom Kyung
    Kim, Seung Up
    Han, Kwang-Hyub
    HEPATOLOGY INTERNATIONAL, 2017, 11 (03) : 292 - 299
  • [47] Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma
    Sun, Sha-Sha
    Guo, Xiao-Di
    Li, Wen-Dong
    Chen, Jing-Long
    WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (02)
  • [48] Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
    Sacco, Rodolfo
    Tapete, Gherardo
    Simonetti, Natalia
    Sellitri, Rossella
    Natali, Veronica
    Melissari, Sara
    Cabibbo, Giuseppe
    Biscaglia, Lilia
    Bresci, Giampaolo
    Giacomelli, Luca
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2017, 4 : 105 - 109
  • [49] Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma
    Fite, Elliott L.
    Makary, Mina S.
    CANCERS, 2024, 16 (13)
  • [50] Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
    Zhong, Bin-Yan
    Jin, Zhi-Cheng
    Chen, Jian-Jian
    Zhu, Hai-Dong
    Zhu, Xiao-Li
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (02) : 480 - 489
12345